200398-40-9

Basic information

• Product Name: 1-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-3-phenylimidazolidin-2-one
• Synonyms: S-18327
• CAS NO: 200398-40-9
• Molecular Formula: C₂₃H₂₅FN₄O₂
• Molecular Weight: 408.4797
• Mol File: 200398-40-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-3-phenylimidazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-3-phenylimidazolidin-2-one(200398-40-9)
• EPA Substance Registry System: 1-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-3-phenylimidazolidin-2-one(200398-40-9)

Safety Data

• Hazardous Substances Data: 200398-40-9(Hazardous Substances Data)

Usage

Complex structure

The compound has a complex structure, which includes a piperidine ring, an imidazolidinone ring, and a fluoro-benzisoxazole group.

Pharmacological properties

The presence of the piperidine moiety suggests that the compound may exhibit pharmacological properties, as this group is commonly found in many biologically active compounds.

Fluoro-benzisoxazole group

The fluoro-benzisoxazole group indicates potential biological activity, as fluorine substitution can greatly impact a compound's properties.

Imidazolidinone ring

The imidazolidinone ring may contribute to the compound's stability and pharmacokinetic properties.

Potential use in pharmaceutical research and drug development

Due to its unique structure and potential pharmacological properties, this compound has the potential to be used in pharmaceutical research and drug development.

Fluorine substitution

The presence of a fluorine atom in the compound can significantly impact its properties, including its reactivity, lipophilicity, and metabolic stability.

Biological activity

The combination of the piperidine, fluoro-benzisoxazole, and imidazolidinone groups suggests that the compound may have biological activity, which could be useful in the development of new drugs.

Stability

The imidazolidinone ring may contribute to the compound's stability, making it more suitable for use in pharmaceutical applications.

Pharmacokinetic properties

The presence of the imidazolidinone ring may also impact the compound's pharmacokinetic properties, such as its absorption, distribution, metabolism, and excretion.

Structure-activity relationship

The specific arrangement of the functional groups in the compound may influence its biological activity and pharmacological properties, making it an interesting target for further research and optimization.

Relevant articles and documents

3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds

Compounds of formula: STR1 wherein: A, m, n, E and Y are as defined in the description, the optical isomers thereof and the physiologically-tolerable salts thereof. These compounds, their optical isomers and their physiologically-tolerable salts, can be u